ICU Medical (ICUI) Stock: Buy, Sell, or Hold?
ICUI - ICU Medical Inc
$165.83
4.99 (3.10%)
▲
5d:
-0.84%
30d:
+1.54%
90d:
+5.33%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When ICUI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ICUI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ICUI shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$222.69
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$138.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICUI is currently trading at $165.83, which is considered extended relative to its 30-day fair value range of $156.61 to $164.31. The stock's valuation (Forward PE: 16.7) is in line with its historical norms (16.4). At these levels, the market is pricing in 0.6% annual earnings growth.
Technical Outlook: Technically, ICUI is in a uptrend. The price is approaching resistance at $167.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: ICUI scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $193.38 (+20.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICUI is in a uptrend. The price is approaching resistance at $167.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: ICUI scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $193.38 (+20.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$156.61 -
$164.31
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
36.7%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 20.2% below Wall St target ($193.38)
- BULLISH: Expecting earnings turnaround to 0.6% growth with 0.5% revenue growth
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$156.61 -
$164.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$157.46
Resistance Level
$167.80
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.67
Wall Street Target
$193.38
(+20.2%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
-46.9%
Profit Margin
1.4%
Valuation Premium vs History
+0.6% premium
PE vs Historical
16.7 vs 16.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$161.81
(+1%)
2-Year Target
$162.78
(+1%)
3-Year Target
$163.75
(+2%)
3-Yr Target (if PE normalizes)
(PE: 17→16)
PE COMPRESSION
$161.06
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 10.2%)
$256.46
(+60%)
Base:
(SPY PE: 16.7, Growth: 10.2%)
$215.32
(+34%)
Bear:
(PE: 14.2, Growth: 10.2%)
$183.02
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Forward PE: 16.95 | Forward EPS (Implied): $9.49
Bull Case
$194.21
(+21%)
Analyst growth 15.0%, PE expands to 17.8
Base Case
$160.84
(0%)
Market implied 0.0%, PE stable at 17.0
Bear Case
$123.04
(-24%)
Severe decline -15.0%, PE contracts to 15.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 1:57 PM ET
Data refreshes hourly during market hours. Next update: 2:57 PM
Data refreshes hourly during market hours. Next update: 2:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICUI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 32 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 37 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 41 HOLD |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 63 BUY |
